Sichuan Kelun Pharmaceutical
China 12 employees Updated 9 July 2026
Sichuan Kelun Pharmaceutical is an API manufacturer based in China. It holds 17 active US drug master files across a filed portfolio of 17 molecules. Its filings concentrate with ARCSA (EC), UZPHARM (UZ) and NAFDAC (NG). Its GMP standing is certified by NAFDAC (NG), UZPHARM (UZ) and ANVISA (Brazil), among 4 authorities.
5
registered plants
1 with an FDA FEI number
33
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Qionglai, China | Not on file |
| SICHUAN, China | Not on file |
| China, China | 3026331762 |
| Hunan Province, Nigeria | Not on file |
| P.R. CHINA, Nigeria | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Apalutamide | US FDA | 1 |
| Aprepitant | US FDA | 1 |
| Empagliflozin | US FDA | 1 |
| Enzalutamide | US FDA | 1 |
| Finerenone | US FDA | 1 |
| Ibrutinib | US FDA | 1 |
| Neratinib | US FDA | 1 |
| Netupitant | US FDA | 1 |
| Nintedanib | US FDA | 1 |
| Olaparib | US FDA | 1 |
Show all 17 molecules on file
| Omadacycline | US FDA | 1 |
| Pemafibrate | US FDA | 1 |
| Posaconazole | US FDA | 1 |
| Regorafenib | US FDA | 1 |
| Sacubitril | US FDA | 1 |
| Sildenafil | US FDA | 1 |
| Siponimod | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| ARCSA (EC) | 16 | None |
| UZPHARM (UZ) | 11 | 1 |
| NAFDAC (NG) | 6 | 2 |
| ANVISA (Brazil) | None | 1 |
| NCELS (KZ) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Sichuan Kelun Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates